The screening mammography paradox: better when found, perhaps better not to find
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6604349.pdf
Reference14 articles.
1. Bazell R (1998) Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer. New York: Random House
2. Berry DA, Cirrincione C, Henderson IC, Citron ML, Budman DR, Goldstein LJ, Martino S, Perez EA, Muss HB, Norton L, Hudis C, Winer EP (2006a) Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 295: 1658–1667, Erratum in: JAMA 295: 2356, doi: 10.1001/jama.295.14.1658
3. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JDF, Feuer EJ, Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353: 1784–1792
4. Berry DA, Inoue L, Shen Y, Venier J, Cohen D, Bondy M, Theriault R, Munsell MF (2006b) Modeling the impact of treatment and screening on US breast cancer mortality: a Bayesian approach. J Natl Cancer Inst Monogr 36: 30–36
5. Fryback DG, Stout NK, Rosenberg MA, Trentham-Dietz A, Kuruchittham V, Remington PL (2006) The wisconsin breast cancer epidemiology simulation model. J Natl Cancer Inst Monogr 36: 37–47
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lead-time bias in esophageal cancer screening in high-risk areas in China;Chinese Journal of Cancer Research;2020
2. Massascreening met mammografie: feiten en misleiding;Huisarts en wetenschap;2019-09-21
3. Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast Cancer;JNCI Cancer Spectrum;2019-08-10
4. Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer;JNCI: Journal of the National Cancer Institute;2018-04-28
5. Failure of researchers, reviewers, editors, and the media to understand flaws in cancer screening studies: Application to an article inCancer;Cancer;2014-06-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3